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ABSTRACT
Objective: For the past 20 decades, vibrational spectroscopy based studies are undergoing around the world to detect cancer at the earliest stage. 
Since vibrational spectroscopic techniques have the ability to measure the biochemical changes occur during the time of mutation, which may be the 
reason for cell proliferation. Biochemical changes may appear in the tissues and blood before the tumor formation. The objective of this work is to 
study the potential of Raman spectroscopy to detect biochemical changes in the normal and malignant tissues.
Methods: In this research work, 10 Raman spectra were acquired from ex vivo samples of human breast tissue (normal and lobular carcinoma) of 
10 patients after the removal during prophylactic mastectomy surgery and biopsy. Data analysis was performed using k-means clustering using SPSS 
and intensity ratio analysis.
Result: Intensity variation in the Raman spectra of normal and malignant tissues clearly indicate that Raman spectra are capable to distinguish 
between normal and malignant tissues. A number of peaks are more in the case of malignant tissues and the presence of amide I and amide III indicate 
the predominance of protein in malignant tissues. Intensity ratio analysis and K-means clustering analysis also show the significance of protein in 
lobular carcinoma tissues.
Conclusion: This research work proves the potential of Raman spectroscopy to differentiate between the normal breast tissues and lobular carcinoma 
tissues.
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INTRODUCTION
Breast cancer is the most widespread and invasive cancer among 
women all over the world. Although the majority of fundamental 
causes and other features are usually the same around the world, 
every region has its own unique feature of the disease. In India, more 
number of patients being diagnosed with breast cancer happens to be 
young. Factors such as obesity, smoking, lack of breastfeeding, lack of 
exercise, and hormonal therapies are the main cause of the increasing 
occurrence of breast cancer in India [1].
The breast is made up of glands called lobules that can make milk 
and thin tubes called ducts that carry the milk from the lobules to the 
nipple. Breast tissue is made up of fat and connective tissue, lymph 
nodes, and blood vessels. The most common type of breast cancer is 
ductal carcinoma, which begins in the cells of the ducts. Breast cancer 
can also begin in the cells of the lobules and in other tissues of the 
breast. It is a heterogeneous disease with different subtypes [2]. Ductal 
carcinoma in situ is a condition in which abnormal cells are found in the 
lining of the ducts without spreading outside them. Breast cancer that 
has spread from where it begins in the ducts or lobules to surrounding 
tissue is called invasive breast cancer. Invasive lobular carcinoma (ILC), 
which is also called as infiltrating lobular carcinoma, is the second 
most common type of breast cancer after invasive ductal carcinoma. 
ILC begins in milk-producing lobules, which empty out into the ducts 
that carry milk to the nipple and spreads to or invades, the surrounding 
breast tissues, lymph nodes, and other areas of the body. ILC can affect 
women at any age, but it is common among older women. Some of the 
studies show that the hormone replacement therapy during and after 
menopause can increase the risk of ILC [3-5].
There are many tests and procedures used to screen breast cancer. The 
most common tests are a blood test, including complete blood count, 
mammogram, magnetic resonance imaging, computed tomography 
scan, bone scan, and positron-emission tomography. However, breast 
biopsy is the only definitive way to diagnose breast cancer. A biopsy 
is a confirmation test before the treatment procedure begins because 
the biopsy sample is used to analyze and determine the type of cells 
involved in breast cancer, the aggressiveness (grade) of the disease and 
whether the cancer cells have hormone receptors or other receptors 
that may influence the treatment options. Unfortunately, even this 
invasive examination cannot ensure a 100% correct diagnosis. ILC is 
likely to be more difficult to detect on Mammograms, because instead 
of forming a tumor, the cancer cells, more typically, spread to the 
surrounding connective tissue in a line formation and the symptoms 
include swelling and change in the surface of the skin with the nipple 
turning inward. All cancer stages are followed by fundamental changes 
in the cellular morphology and tissue biochemistry. Changes in the cells 
such as distribution of DNA, lipids, and proteins emerge before the 
clinical symptoms appear. These changes can be considered as early 
marks in the detection of cancer using optical techniques like Raman 
spectroscopy [6].
Optical technologies such as Raman spectroscopy, to provide 
diagnostic information about a suspicious lesion are gaining 
more attention in the field of cancer research. A Raman spectrum 
represents the molecular fingerprint of the sample and provides 
quantitative information regarding its chemical makeup. Biochemical 
changes in cells and tissues that may either be caused by or are the 
cause of, a disease, can lead to significant changes in the Raman 
spectra. Raman images reveal an inhomogeneous distribution of 
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different compounds, especially proteins, lipids, microcalcifications, 
and their metabolic products, in cancerous breast tissues. In contrast 
to other optical spectroscopic techniques, there are a large number of 
Raman active molecules in breast tissue and their spectral signatures 
are sharp and well delineated. The ability to probe several different 
chemicals is of particular importance in studying breast cancer, 
due to the heterogeneity of breast disease. Raman spectroscopy is 
particularly amenable to in vivo measurements as the powers and 
excitation wavelengths used are non-destructive to the tissue and 
have a relatively large penetration depth. The aim of this study is to 
exploit the potential of Raman spectroscopy to study the biomarkers 
among cancerous and normal tissues [7-9].
EXPERIMENTAL
Sample collection and pre-treatment
This project was taken up under a protocol approved by the 
Karpagam Faculty of Medical Sciences and Research (IHEC/80/
Physics/03/2017), Coimbatore, India. Lobular carcinoma tissues 
from 10 patients and tissues from the safety margin outside the tumor 
mass were examined. Tissues were collected during prophylactic 
mastectomy surgery and biopsy. A small portion of the samples 
was cryosectioned and stored in ethanol for preservation. Stored 
samples were used for Raman spectroscopic analysis and other parts 
of the tissue samples were subjected to histopathological analysis. 
Histological analysis was performed at the Department of Pathology, 
Karpagam Faculty of Medical Sciences and Research. The use of the 
samples for research did not affect the course of the operation or 
treatment of the patient.
Recording Raman spectra
Raman spectra of lobular carcinoma tissue samples and normal tissue 
samples were recorded with Witech microscope and Nd: YAG laser 
operating wavelength at 745 nm and output power of 17 mW. The 
signal was collected keeping integration time 30 s and the power 
density of the laser as minimum as possible. The recorded spectra were 
in the range of 300–3600 cm−1.
Analysis of Raman spectral data
The collected spectra underwent baseline correction and filtering by 
the FFT algorithm using Origin 6.0. A comparative study of lobular and 
normal tissue samples was made within the conventional fingerprint 
region (500 cm−1–1800 cm−1). A statistical tool like k-means clustering 
analysis was used to differentiate between normal and malignant 
tissues. The relative intensity analysis was also helpful to differentiate 
between normal and malignant tissues.
RESULTS AND DISCUSSION
The mean Raman spectra and bond assignments of normal and 
malignant tissues
In this section, Raman spectra of non-cancerous and lobular carcinoma 
tissues of the same patients are represented. To rationalize the 
vibrational features of the malignant pathology, a comparison between 
the Raman spectra of the lobular carcinoma tissue and normal tissue is 
made. Fig. 1(a and b) represents the Raman spectra of lobular and normal 
breast tissues respectively.
If the spectra of normal and lobular carcinoma tissues are compared, a 
clear intensity and peak variations in the spectra are evident (Table:1). 
Especially, in lobular carcinoma tissue spectra, the number of peaks 
is more compared to normal, and a clear Raman shift is also visible in 
the case of PO2 symmetric stretching of proteins, lipids, and amide III. 
The level of amide III, amide I, and PO2 symmetric stretching of lipids 
is predominantly higher than that of normal tissue [12]. Previous 
researches also indicate the predominance of proteins and amino acids 
in the malignant tissues [11,13]
Intensity ratio analysis
Human tissues are composed of proteins, lipids, nucleic acids, amide, 
Fig. 1: (a and b) Raman spectra of lobular carcinoma tissues and normal tissues
ba
Fig. 2: (a and b) K-means cluster analysis of non-cancerous and lobular carcinoma tissues
ba
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and so on. To differentiate between lobular carcinoma tissues and 
noncancerous tissues, the intensity ratio analysis is carried out. To 
carry out intensity ratio analysis, four characteristic peaks are chosen 
and four coordinate height is measured in both noncancerous tissues 
(H886, H1281, H1456, and H1666) and malignant tissues (H886, 
H1253, H1453, and H1659), respectively. Then, the ratios are calculated 
for comparison.
The band around 886 cm-1 is due to the presence of lipids and 1281 
and 1253 cm−1 indicating the presence of proteins. The H1253/
H886 and H1281/H886 (protein/lipid) ratio for cancerous and 
noncancerous tissues are 0.7372 and 0.1564, respectively. This 
indicates the predominance of proteins in the cancerous tissues. 
Similarly, H1456/H886 and H1453/H886 (Amide III/Lipid) ratio 
show that the presence of amide III is more in malignant tissues 
compared to noncancerous tissues. Most of the studies show that the 
amount of protein content is more in cancerous tissue compared to 
normal tissues. This study also confirms recent studies, which have 
shown that the increase in protein content may be one of the reasons 
for metastasis [14].
Similarly, the band at 1666 and 1659 cm−1 shows the presence of 
amide I, and the intensity ratio analysis reveals a significant difference 
between the ratio of amides and lipids. In this case also the presence 
of amide I is more in cancerous tissues compared to normal tissues 
(0.2985>0.0304). All these results indicate that the presence of protein 
and its compounds is more in malignant tissues [15].
K-means cluster analysis
In this study, k-means clustering analysis is used to statistically confirm 
the importance of protein content in cancerous tissues. Like intensity 
analysis, four biomolecular assignments such as protein, amide I, amide 
III, and lipid are selected. From the bar plot of k-means clustering 
analysis Fig 2 (a and b), it is obvious that there is a significant difference 
in the cluster1, cluster 2, and cluster 3 of malignant and normal breast 
tissues. If the f-value of normal and malignant samples is considered, it 
clearly shows a significant difference between normal and malignant 
samples and also the predominance of protein in the lobular carcinoma 
samples [16].
In this present study, SPSS software is used for k-means clustering 
analysis to find the significance of biomolecules. The f values of 
protein f= (32), amide I (f=15), and amide III (f=21) from k-means 
that clustering for malignant tissues is high compared to lipids (f=14), 
whereas in normal tissues the value of lipids are more. In the normal 
tissue significance of lipid (f=64) is high, while that of protein (f=47), 
amide I (f=11), and amide III (f=31) are not. The result shows that 
protein and its components have a significant impact on the malignant 
cluster and lipid has a significant impact on the noncancerous 
cluster [17].
CONCLUSION
Micro Raman spectroscopy study of ex vivo measurement of normal 
and lobular carcinoma tissues based on the statistical analysis has 
been reported in this work. Raman spectra of noncancerous and 
lobular carcinoma tissue samples point out an important difference in 
the band characteristics of protein and lipid. Using k-means clustering 
analysis, the significance of protein in the lobular carcinoma tissues 
is proved. The intensity ratio analysis also shows that the protein 
content is more in malignant tissues and lipid content stronger in 
noncancerous tissues.
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